Infants diagnosed with biliary atresia who receive a living-donor liver transplant (LDLT) have lower overall healthcare costs than those who receive a deceased-donor liver transplant (DDLT), demonstrated by a new research study led by Amy Feldman, MD, PhD, Medical Director of the Liver Transplant Program at Children's Hospital Colorado (Children's Colorado).